Development of Dual Language (Urdu and English) Digital Software for SA, Management Of Adult Dysarthria

Not Applicable

Active, not recruiting

• Conditions: Dysarthria

• Registration Number: NCT07129291
• Lead Sponsor: Superior University

Brief Summary

The research focuses on the development of a dual-language (Urdu and English) digital software designed for the self-assessment and management of adult dysarthria patients. Dysarthria, a motor speech disorder resulting from neurological injury, significantly affects an individual's ability to communicate effectively.

Detailed Description

Current assessment tools are often clinician-dependent and predominantly available in English, limiting accessibility for non-English speakers, especially in Pakistan and other Urdu-speaking regions. This study aims to bridge that gap by creating a user-friendly, culturally relevant, and linguistically accessible software platform. The software will enable adult dysarthric patients to monitor their speech abilities, track progress, and participate more actively in their therapy process. It is expected to enhance patient autonomy, improve communication outcomes, and support speech-language pathologists in delivering more efficient care. The dual-language interface ensures broader usability, promoting inclusion and better engagement among diverse user groups in bilingual settings.

Study Timeline

• Study Start: 2025-04-17
• Status Verified: 2025-08
• Study First Submitted: 2025-08-12
• Study First Submitted QC: 2025-08-12
• Last Update Submitted: 2025-08-12
• Study First Posted: 2025-08-19
• Last Update Posted: 2025-08-19
• Primary Completion: 2026-04-01
• Study Completion: 2027-03-01

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Adults (18+) diagnosed with dysarthria due to neurological causes (e.g., stroke, Parkinson's).
• Able to understand and communicate in Urdu and/or English.
• Cognitive ability sufficient to use digital tools for self-assessment.
• Consent to participate in the study.

Exclusion Criteria

• Severe cognitive impairment or dementia limiting participation.
• Co-existing speech disorders unrelated to dysarthria (e.g., aphasia).
• Hearing impairments that prevent use of audio-based software.
• Unwillingness or inability to use digital devices.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Frenchay Dysarthria Assessment (FDA-2)	24 Months	Assesses: Motor speech function. Scoring: A (normal) to E (severely impaired) across speech subsystems.
Dysarthria Impact Profile (DIP)	24 Months	Assesses: Psychosocial impact of dysarthria. Scoring: 48 items, rated 1-5; higher scores = greater negative impact.
Speech Intelligibility Rating Scale (SIRS)	24 Months	Assesses: Speech clarity. Scoring: 1 (unintelligible) to 5 (fully intelligible).
Voice Handicap Index-10 (VHI-10) (optional)	24 Months	Assesses: Patient's perception of voice issues. Scoring: 0-4 per item; total out of 40. Higher = more voice difficulty.

Trial Locations

Locations (1)

Rehabilitation Centers in Punjab; 🇵🇰 Lahore, Punjab, Pakistan